The aim of the present study was to evaluate the effect of an anti-YKL-40 monoclonal antibody on tumor growth and morphology in a xenograft model of human melanoma and pancreatic adenocarcinoma in scid mice previously established in our lab [29], [30]. This evidence concerns the gene CHI3L1 and neoplasm.